Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thijs Roelofsen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Medical Hypotheses|December 22, 2009
The origin of serous ovarian cancer may be found in the uterus: a novel hypothesisLeon Massuger, Thijs Roelofsen, Maaike van Ham, et al.
Expert Review of Anticancer Therapy|December 21, 2010
Clinical management of uterine papillary serous carcinomaThijs Roelofsen, Maaike A van Ham, Joanne A de Hullu, et al.
EMBO Reports|May 2, 2006
Histone modification patterns associated with the human X chromosomeArie B Brinkman, Thijs Roelofsen, Sebastiaan W C Pennings, et al.
Plos One|December 19, 2009
Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in miceStefan Nierkens, Martijn H den Brok, Thijs Roelofsen, et al.
Frontiers in Oncology|December 18, 2018
Spontaneous Regression of Ovarian Carcinoma After Septic Peritonitis; A Unique Case ReportThijs Roelofsen, Christina Wefers, Mark A J Gorris, et al.
Obstetrics and Gynecology|November 22, 2012
Pure compared with mixed serous endometrial carcinoma: two different entities?Thijs Roelofsen, Maaike A P C van Ham, Johanna M Wiersma van Tilburg, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 18, 2012
Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?Thijs Roelofsen, Léon C L T van Kempen, Jeroen A W M van der Laak, et al.
The International Journal of Biological Markers|August 7, 2012
Preoperative CA-125 predicts extra-uterine disease and survival in uterine papillary serous carcinoma patientsThijs Roelofsen, Marjanka Mingels, Jan C M Hendriks, et al.
Gynecologic Oncology|June 20, 2012
Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controlsMarjanka J J M Mingels, Thijs Roelofsen, Jeroen A W M van der Laak, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 1, 2013
Cervical cytology in serous and endometrioid endometrial cancerThijs Roelofsen, Yvette P Geels, Johanna M A Pijnenborg, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Medical Hypotheses|December 22, 2009
The origin of serous ovarian cancer may be found in the uterus: a novel hypothesisLeon Massuger, Thijs Roelofsen, Maaike van Ham, et al.
Expert Review of Anticancer Therapy|December 21, 2010
Clinical management of uterine papillary serous carcinomaThijs Roelofsen, Maaike A van Ham, Joanne A de Hullu, et al.
EMBO Reports|May 2, 2006
Histone modification patterns associated with the human X chromosomeArie B Brinkman, Thijs Roelofsen, Sebastiaan W C Pennings, et al.
Plos One|December 19, 2009
Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in miceStefan Nierkens, Martijn H den Brok, Thijs Roelofsen, et al.
Frontiers in Oncology|December 18, 2018
Spontaneous Regression of Ovarian Carcinoma After Septic Peritonitis; A Unique Case ReportThijs Roelofsen, Christina Wefers, Mark A J Gorris, et al.
Obstetrics and Gynecology|November 22, 2012
Pure compared with mixed serous endometrial carcinoma: two different entities?Thijs Roelofsen, Maaike A P C van Ham, Johanna M Wiersma van Tilburg, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 18, 2012
Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?Thijs Roelofsen, Léon C L T van Kempen, Jeroen A W M van der Laak, et al.
The International Journal of Biological Markers|August 7, 2012
Preoperative CA-125 predicts extra-uterine disease and survival in uterine papillary serous carcinoma patientsThijs Roelofsen, Marjanka Mingels, Jan C M Hendriks, et al.
Gynecologic Oncology|June 20, 2012
Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controlsMarjanka J J M Mingels, Thijs Roelofsen, Jeroen A W M van der Laak, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 1, 2013
Cervical cytology in serous and endometrioid endometrial cancerThijs Roelofsen, Yvette P Geels, Johanna M A Pijnenborg, et al.
Pageof 2